A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
A Phase 3 Study of Sodium Thiosulfate for Reduction of Cisplatin-Induced Ototoxicity in Children With Average-Risk Medulloblastoma and Reduced Therapy in Children With Medulloblastoma With Low-Risk Features
-
Clinical Trial Information
Trial Contact: Dubberly, Paige D; Spinelli, Jennifer; Armatti, Julie M; Parker, Melanie; Doyle, Katherine M
Trial Phone: 321-841-7561 ; 321.841.5357 ; 321-843-5284 ; 321-843-1036 ; 3218412008
-
IRB No: ACNS2031
Protocol Abbrev: ACNS2031
Principal Investigator: Amy A. Smith, MD
Phase: Drug: Phase III
Age Group: Pediatric
ClinicalTrials.gov ID: NCT05382338
-
Objective
This phase III trial tests two hypotheses in patients with low-risk and average-risk medulloblastoma. Medulloblastoma is a type of cancer that occurs in the back of the brain.
